The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 6,084 | 35,350 | SH | SOLE | 35,350 | 0 | 0 | ||
| ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 779 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 6,300 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| ACUTUS MED INC | COM | 005111109 | 1,768 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,736 | 197,759 | SH | SOLE | 197,759 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 1,064 | 111,400 | SH | SOLE | 111,400 | 0 | 0 | ||
| ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 6,036 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 6,941 | 702,500 | SH | SOLE | 702,500 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 5,724 | 35,910 | SH | SOLE | 35,910 | 0 | 0 | ||
| ASLAN PHARMACEUTICALS LTD | ADS | 04522R101 | 445 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 3,267 | 532,030 | SH | SOLE | 532,030 | 0 | 0 | ||
| BERKELEY LTS INC | COM | 084310101 | 1,076 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 1,042 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 30,673 | 654,435 | SH | SOLE | 654,435 | 0 | 0 | ||
| BUTTERFLY NETWORK INC | COM CL A | 124155102 | 1,566 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| CASSAVA SCIENCES INC | COM | 14817C107 | 4,656 | 75,000 | SH | Put | SOLE | 75,000 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 2,168 | 40,154 | SH | SOLE | 40,154 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 3,393 | 203,183 | SH | SOLE | 203,183 | 0 | 0 | ||
| CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 7,669 | 259,966 | SH | SOLE | 259,966 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 949 | 74,341 | SH | SOLE | 74,341 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 242 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 4,502 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 2,108 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 4,468 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 636 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 4,108 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| ENVIRONMENTAL IMPACT ACQU CO | COM CL A | 29408N106 | 2,967 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 4,295 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| GALAPAGOS NV | SPON ADR | 36315X101 | 1,052 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 1,911 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 2,087 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
| HARPOON THERAPEUTICS INC | COM | 41358P106 | 1,975 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 2,967 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 1,643 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| IMMATICS N.V | *W EXP 07/01/2020 | N44445117 | 800 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 261 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
| INARI MED INC | COM | 45332Y109 | 10,949 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| INNATE PHARMA S A | SPONSORED ADS | 45781K204 | 771 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 2,012 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 3,699 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 495 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 9,927 | 530,000 | SH | SOLE | 530,000 | 0 | 0 | ||
| LIFESCI ACQUISITION II CORP | COM | 53229E103 | 1,470 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 2,925 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/2026 | G5960S124 | 24 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 1,573 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 4,865 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
| MORPHIC HLDG INC | COM | 61775R105 | 15,336 | 270,755 | SH | SOLE | 270,755 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 3,601 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 5,987 | 975,000 | SH | SOLE | 975,000 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 7,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 2,996 | 78,534 | SH | SOLE | 78,534 | 0 | 0 | ||
| PULMONX CORP | COM | 745848101 | 900 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| RAFAEL HLDGS INC | COM CL B | 75062E106 | 3,110 | 101,200 | SH | Put | SOLE | 101,200 | 0 | 0 | |
| RENOVACOR INC | COM | 75989E106 | 1,041 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 60 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 2,398 | 80,228 | SH | SOLE | 80,228 | 0 | 0 | ||
| SCHRODINGER INC | COM | 80810D103 | 1,367 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| SEER INC | COM CL A | 81578P106 | 1,727 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 42,914 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| SPDR SER TR | S&P BIOTECH | 78464A870 | 87,997 | 700,000 | SH | Put | SOLE | 700,000 | 0 | 0 | |
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 7,994 | 126,013 | SH | SOLE | 126,013 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 647 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| THE BEAUTY HEALTH COMPANY | *W EXP 05/04/2026 | 88331L116 | 498 | 34,400 | SH | SOLE | 34,400 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 4,850 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 7,056 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 3,512 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 1,846 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 1,269 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| VINCERX PHARMA INC | COM NEW | 92731L106 | 16,251 | 1,005,000 | SH | SOLE | 1,005,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 764 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 5,165 | 77,500 | SH | SOLE | 77,500 | 0 | 0 | ||
| ZYMEWORKS INC | COM | 98985W102 | 1,127 | 38,814 | SH | SOLE | 38,814 | 0 | 0 | ||